- Home
- MLYS vs HGTY Comparison
MLYS vs HGTY Comparison
Compare MLYS & HGTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- HGTY
- Stock Information
- Founded
- MLYS 2019
- HGTY 1984
- Country
- MLYS United States
- HGTY United States
- Employees
- MLYS N/A
- HGTY N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- HGTY Specialty Insurers
- Sector
- MLYS Health Care
- HGTY Finance
- Exchange
- MLYS Nasdaq
- HGTY Nasdaq
- Market Cap
- MLYS 1.0B
- HGTY 820.4M
- IPO Year
- MLYS 2023
- HGTY N/A
- Fundamental
- Price
- MLYS $15.58
- HGTY $9.72
- Analyst Decision
- MLYS Strong Buy
- HGTY Hold
- Analyst Count
- MLYS 3
- HGTY 3
- Target Price
- MLYS $33.00
- HGTY $10.50
- AVG Volume (30 Days)
- MLYS 866.7K
- HGTY 78.2K
- Earning Date
- MLYS 05-12-2025
- HGTY 05-07-2025
- Dividend Yield
- MLYS N/A
- HGTY N/A
- EPS Growth
- MLYS N/A
- HGTY 124.60
- EPS
- MLYS N/A
- HGTY 0.20
- Revenue
- MLYS N/A
- HGTY $1,247,923,000.00
- Revenue This Year
- MLYS N/A
- HGTY $16.08
- Revenue Next Year
- MLYS N/A
- HGTY $16.80
- P/E Ratio
- MLYS N/A
- HGTY $47.75
- Revenue Growth
- MLYS N/A
- HGTY 18.45
- 52 Week Low
- MLYS $8.24
- HGTY $8.03
- 52 Week High
- MLYS $18.38
- HGTY $12.35
- Technical
- Relative Strength Index (RSI)
- MLYS 54.41
- HGTY 58.99
- Support Level
- MLYS $15.45
- HGTY $9.08
- Resistance Level
- MLYS $16.11
- HGTY $9.99
- Average True Range (ATR)
- MLYS 0.96
- HGTY 0.36
- MACD
- MLYS -0.05
- HGTY 0.00
- Stochastic Oscillator
- MLYS 51.56
- HGTY 70.33
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About HGTY Hagerty Inc.
Hagerty Inc is a provider of specialty automotive insurance. The company underwrites, sells, and services classic car and enthusiast vehicle insurance policies. Substantial revenue is derived from Commission and fees. Geographically it serves Europe, Canada, and the United States.